Abstract
STARfloTM is a new glaucoma drainage device (GDD) comprised entirely of Healionics’ proprietary STAR® Biomaterial, a precision-pore structured silicone. The STARfloTM relies on extensive research and studies conducted for several years on the STAR® Biomaterial as implantable material and on STARflo predecessors in the ophthalmic field – the CELLplant and the ClarifEYE. The device’s bleb-free drainage mechanism, soft-sponge design, and fibrosis-resistant pore geometry give it several advantages over competing GDDs. The safety and the performances of the STARflo device were demonstrated on animals while early results on human shows encouraging results in the control of the IOP with a reduction of glaucoma medications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bill A, Philips CI. Uveoscleral drainage of aqueous humor in human eye. Exp Eye Res. 1971;12(3):275–81.
Toris CB, Yablonski ME, Wang YL, Camras CB. Aqueous humor dynamics in the aging human eye. Am J Ophthalmol. 1999;127(4):407–12.
Weinreb RN. Uveoscleral outflow: the other outflow pathway. J Glaucoma. 2000;9(5):343–5.
Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL. Effects of prostaglandins on the aqueous humor outflow pathways. Surv Ophthalmol. 2002;47 Suppl 1:S53–64.
Mosaed S, Minckler DS. Aqueous shunt in the treatment of glaucoma. Expert Rev Med Devices. 2010;7(5):661–6.
Boyle JW, Netland PA. Incisional therapies: shunts and valved implants. In: Schacknow PN, Samples JR, editors. The glaucoma book – a practical, evidence-based approach to patient care. New York: Springer; 2010. p. 813–30.
Ratner BD, Marshall A, inventors; University of Washington, assignee. Porous biomaterials. United States patent US 7972628 B2, 5 July 2011.
Ratner BD, Marshall A, inventors; University of Washington, assignee. Crosslinked porous biomaterials. United States Patent US 8318193, 27 Nov 2012.
Ratner BD, Marshall A, inventors; University of Washington, assignee. Novel porous biomaterials that support vascular in-growth. European Patent EP 1670385, 23 Jan 2013.
Nordquist RE, Li B, inventors; Wound Healing of Oklahoma, assignee. Method and apparatus for lowering the intraocular pressure of an eye. United States Patent US 5704907, 6 Jan 1998.
Nordquist RE, Li B, inventors; Premier Laser Systems Inc., assignee. Method and apparatus for lowering the intraocular pressure of an eye. United States Patent US 6102045, 15 Aug 2000.
Rollet M, Moreau M. Traitement de l’hypopyon par le drainage capillaire de la chambre antérieure. Rev Gen Ophthalmol (Paris). 1906;25:481–9. French.
Hong C-HH, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol. 2005;50(1):48–60.
Luntz MH, Harrison R. Alloplastic devices in glaucoma surgery: setons. In: Lim ASM, series editor. Glaucoma surgery. Singapore: World Scientific; 1994. p. 153–63.
Lisk JR, Memmen JE, Hampton SM, Nordquist RE, Robledo PV, Tai M-K, inventors; Medtronic-Xomed INc, assignee. Article and method for ocular aqueous drainage. United States Patent US 7160264 B2, 9 Jan 2007.
Lisk JR, Memmen JE, Hampton SM, Nordquist RE, Robledo PV, Tai M-K, inventors; Medtronic-Xomed Inc., assignee. Device for ocular aqueous drainage. European Patent EP 1578319B1, 23 Jan 2010.
Sabbagh L. Early results good with glaucoma seton. Ophthalmol Times. 1995;20(40):10–2.
Intraocular Implantation Study in the Rabbit. NAMSA study protocol and report # 02T0101300, 2002.
Martson M, Viljanto J, Hurme T, Laippala P, Saukko P. Is cellulose degradable or stable as implantation material? An in vivo subcutaneous study in the rat. Biomaterials. 1999;20(21):1989–95.
Marshall AJ, Ratner BD. Quantitative characterization of sphere-templated porous biomaterials. AIChE J. 2005;51(4):1221–32.
Marshall A. Hydrogels with well-defined pore structure for biomaterials applications. PhD dissertation, University of Washington; 2004: AAT 3151637.
Krombach F, Münzing S, Allmeling AM, Gerlach JT, Behr J, Dörger M. Cell size of alveolar macrophages: an interspecies comparison. Environ Health Perspect. 1997;105 Suppl 5:1261–3.
Brauker JH, Carr-Brendel VE, Martinson LA, Crudele J, Johnston WD, Johnson RC. Neovascularization of synthetic membranes directed by membrane microarchitecture. J Biomed Mater Res. 1995;29(12):1517–24.
Sharkaway AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J Biomed Mater Res. 1998;40(4):586–97.
Bae HB, Kim CS, Ahn BH. A membranous drainage implant in glaucoma filtering surgery: animal trial. Korean J Opthalmol. 1988;2:49–56.
Terasaki D, Sobel M, Irvin C, Wijelath E, Ratner BD. Biomaterial-Induced Angiogenesis To Adress Peripheral Vascular Disease: The Application of Sphere Templated Hydrogels. In: Scholz C, Kressler J, editors. Tailored polymer architectures for pharmaceutical and biomedical applications. ACS Symp Ser 2013. p. 245–57.
Madden LR, Mortisen DJ, Sussman EM, Dupras SK, Fugate JA, Cuy JL, et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc Natl Acad Sci U S A. 2010;107(34):15211–6.
Marshall AJ, Alvarez M, Maginness M, inventors; Healionics Corporation, assignee. Implantable medical devices having microporous surface layers and method for reducing foreign body response to the same. United States Patent US 2011/0257623 A1, 20 Oct 2011.
Ayyala RS, Michelini-Norris B, Flores A, Haller E, Margo CE. Comparison of different biomaterials for glaucoma drainage devices: part 2. Arch Ophthalmol. 2000;118(18):1081–4.
Ocular Irritation Study of STARflo glaucoma implant following implantation in the anterior chamber of the rabbit eye. NAMSA study protocol and report # 10T5296802, 2010.
Biotechnol Bioeng. 2012;109(8):C1.
Roberts S, Woods C. Preliminary report: effect of a novel porous implant in refractory glaucomatous dogs. In: Veterinary ophthalmology. Abstracts: 39th annual meeting of the American College of Veterinary Ophthalmologists, Boston, 15–18 Oct 2008, p. 423.
Acknowledgments
The authors express warm thanks to M. Maginness (PhD, Healionics Corporation), Dr. R.E. Norquist (PhD, Wound Healing Of Oklahoma, Inc.), and Dr. C. Woods (DVM, BioVeteria Life Sciences, LLC) for their contribution and inputs in this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Electronic supplementary material
Below is the link to the electronic supplementary material.
(MOV 13514 kb)
(WMV 405425 kb)
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pourjavan, S., Collignon, N.J.M., De Groot, V., Eiferman, R.A., Marshall, A.J., Roy, C.J. (2014). STARfloTM: A Suprachoroidal Drainage Implant Made from STAR® Biomaterial. In: Samples, J.R., Ahmed, I.I.K. (eds) Surgical Innovations in Glaucoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8348-9_22
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8348-9_22
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8347-2
Online ISBN: 978-1-4614-8348-9
eBook Packages: MedicineMedicine (R0)